TC
VIR icon

TwinBeech Capital’s Vir Biotechnology VIR Stock Holding History

TwinBeech Capital’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-291,416
Closed -$1.89M – 994
2025
Q1 		$1.89M Buy
+291,416
New +$2.59M 0.03% 400
2024
Q1 		– Sell
-319,872
Closed -$3.22M – 872
2023
Q4 		$3.22M Buy
319,872
+220,712
+223% +$2.02M 0.05% 334
2023
Q3 		$929K Buy
+99,160
New +$1.41M 0.02% 500
2023
Q2 		– Sell
-108,507
Closed -$2.52M – 878
2023
Q1 		$2.52M Buy
+108,507
New +$2.78M 0.05% 346
2022
Q4 		– Sell
-165,460
Closed -$3.19M – 954
2022
Q3 		$3.19M Buy
+165,460
New +$4.21M 0.08% 263
2022
Q2 		– Sell
-21,802
Closed -$561K – 744
2022
Q1 		$561K Buy
+21,802
New +$647K 0.02% 384
2021
Q4 		– Sell
-55,974
Closed -$2.44M – 830
2021
Q3 		$2.44M Buy
+55,974
New +$2.42M 0.17% 182

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return